Χώρα: Βέλγιο
Γλώσσα: Αγγλικά
Πηγή: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
Tetanus Toxoid >= 40 IU/dose; Bordetella pertussis Toxoid (PT) 25 µg/dose; Bordetella pertussis Filamentous Hemagglutinin (FHA) 25 µg/dose; Bordetella pertussis Pertactin 8 µg/dose; Diphtheria Toxoid (DT) >= 30 IU/dose
GlaxoSmithKline Biologicals SA-NV
J07AJ52
Diphteria Antigen, Adsorbed; Tetanus Toxoid Adsorbed; Bordetella Pertussis
Suspension for injection in pre-filled syringe
Diphteria Antigen, Adsorbed; Tetanus Toxoid Adsorbed; Bordetella Pertussis
Intramuscular use
Pertussis, Purified Antigen, Combinations with Toxoids
CTI code: 169312-01 - Pack size: 1 dose (0.5 (0.5) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 169312-02 - Pack size: 10 x 1 dose (0.5 (0.5) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 169312-03 - Pack size: 25 x 1 dose (0.5 (0.5) - Commercialisation status: NO - Delivery mode: Medical prescription
Commercialised: No
1995-05-11